BERN, Switzerland, January 4, 2024 (Newswire.com) - LEM Surgical AG, an innovative surgical robotics company headquartered in Bern, Switzerland, announces the successful completion of its Series B funding, securing CHF 22 million. The round, which was strongly oversubscribed, reflects the strong investors’ confidence in LEM Surgical’s differentiated approach. This … [Read more...] about LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission
2024
We are proud to announce that Genesys Spine will be Sponsor of SPINEMarketGroup again in 2024!
Thank you Genesys Spine! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About Genesys Spine Founded in December of 2009, Genesys Spine’s mission was to bring a suite of medical implants and instruments with novel characteristics into a mature spinal fusion market. Since that time, … [Read more...] about We are proud to announce that Genesys Spine will be Sponsor of SPINEMarketGroup again in 2024!
Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
WESTMINSTER, Colo., Jan. 4, 2024 /PRNewswire/ -- Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, today announced that it has filed the final module in the Pre-Market Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its investigational P-15 Peptide Enhanced Bone Graft. … [Read more...] about Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2
KEELE, England, Jan. 4, 2024 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, is pleased to announce that its investee company, Renovos Biologics (Renovos), has been granted Breakthrough Device … [Read more...] about Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2
We are proud to announce that W+S Solutions will be Sponsor of SPINEMarketGroup again in 2024!
Thank you W+S Solutions! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About W+S Solutions GmbH The company W+S Solutions is a family-owned business founded in 2006 in Tuttlingen, Germany. We are specialized in the manufacturing of silicone handles for surgical instruments as … [Read more...] about We are proud to announce that W+S Solutions will be Sponsor of SPINEMarketGroup again in 2024!
We are proud to announce that Intech will be Sponsor of SPINEMarketGroup again in 2024!
Thank you Intech! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About Intech Intech is proud and happy to lead the way in the manufacturing of orthopedic instruments and implants that better patients’ lives.Powered by 1,000 Intechers across the globe, the company is a premiere … [Read more...] about We are proud to announce that Intech will be Sponsor of SPINEMarketGroup again in 2024!
Revolutionizing Spine Surgery: The Rise of Awake Spine Surgery
The field of spine surgery is continuously evolving, with advancements in tools such as robotics, imaging, and artificial intelligence contributing to safer and faster procedures. We've also discussed emerging approaches, materials, and implants. However, in the ever-evolving field of spine surgery, advancements continue to redefine traditional practices, and one such … [Read more...] about Revolutionizing Spine Surgery: The Rise of Awake Spine Surgery
CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market
SEOUL, South Korea, Jan. 2, 2024 /PRNewswire/ -- CGBio (CEO Hyun Seung Yu), a Korean company specializing in bio-regenerative medicine, announced on the 2nd that its advanced bone substitute material, "NOVOSIS PUTTY", has been granted 'Breakthrough Device Designation' (BDD) by the U.S. Food and Drug Administration (FDA). This material incorporates recombinant … [Read more...] about CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market